1H-Pyrazol-5-ol, 4,4'-[(4-ethylphenyl)methylene]bis[3-methyl-1-phenyl- manufacturers
- SARS-CoV-2-IN-31
-
- $2500.00
-
2026-07-27
- CAS:1017691-52-9
- Purity:
- Supply Ability: 10g
|
| | 1H-Pyrazol-5-ol, 4,4'-[(4-ethylphenyl)methylene]bis[3-methyl-1-phenyl- Basic information |
| | 1H-Pyrazol-5-ol, 4,4'-[(4-ethylphenyl)methylene]bis[3-methyl-1-phenyl- Chemical Properties |
| Boiling point | 658.1±50.0 °C(Predicted) | | density | 1.22±0.1 g/cm3(Predicted) | | pka | 8.16±0.50(Predicted) |
| | 1H-Pyrazol-5-ol, 4,4'-[(4-ethylphenyl)methylene]bis[3-methyl-1-phenyl- Usage And Synthesis |
| Uses | SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1]. | | References | [1] Anamika Gupta, et al. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro. ACS Omega 2022. |
| | 1H-Pyrazol-5-ol, 4,4'-[(4-ethylphenyl)methylene]bis[3-methyl-1-phenyl- Preparation Products And Raw materials |
|